InvestorsHub Logo
Followers 335
Posts 18990
Boards Moderated 0
Alias Born 08/25/2007

Re: None

Tuesday, 09/11/2018 3:59:02 PM

Tuesday, September 11, 2018 3:59:02 PM

Post# of 5633
Histogenics to seek FDA approval for cell therapy despite failed study

“We have already seen a number of important results, including a statistically significant improvement of NeoCart compared to microfracture in lesion sizes of greater than 2 cm and patients with higher body mass index. We think that results such as these will be an important part of our planned discussions with the FDA, as well as with clinicians if NeoCart is approved,” continued Dr. Kelley.
https://finance.yahoo.com/m/3a6799a6-d72e-39d7-a336-f6c1cd2f1dc1/histogenics-to-seek-fda.html

DONT LISTEN TO ME IM CANADIANNNNNNNN

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News